Results 31 to 40 of about 3,773 (193)

A-type FHFs mediate resurgent currents through TTX-resistant voltage-gated sodium channels

open access: yeseLife, 2022
Resurgent currents (INaR) produced by voltage-gated sodium channels are required for many neurons to maintain high-frequency firing and contribute to neuronal hyperexcitability and disease pathophysiology. Here, we show, for the first time, that INaR can
Yucheng Xiao   +5 more
doaj   +1 more source

Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes c-fiber nociceptors with broad action potentials and high nav1.9 expression [PDF]

open access: yes, 2006
Binding to isolectin-B4 (IB4) and expression of tyrosine kinase A (trkA) (the high-affinity NGF receptor) have been used to define two different subgroups of nociceptive small dorsal root ganglion (DRG) neurons. We previously showed that only nociceptors
Berry, Carol   +6 more
core   +1 more source

Regulation of the Spontaneous Augmentation of NaV1.9 in Mouse Dorsal Root Ganglion Neurons: Effect of PKA and PKC Pathways

open access: yesMarine Drugs, 2010
Sensory neurons in the dorsal root ganglion express two kinds of tetrodotoxin resistant (TTX-R) isoforms of voltage-gated sodium channels, NaV1.8 and NaV1.9. These isoforms play key roles in the pathophysiology of chronic pain.
Nobukuni Ogata   +3 more
doaj   +1 more source

The role of Nav1.9 channel in the development of neuropathic orofacial pain associated with trigeminal neuralgia [PDF]

open access: yes, 2015
BACKGROUND: Trigeminal neuralgia is accompanied by severe mechanical, thermal and chemical hypersensitivity of the orofacial area innervated by neurons of trigeminal ganglion (TG).
Kopach, O   +3 more
core   +1 more source

Defining the Voltage Sensor Properties and Pharmacology of Nav1.9 [PDF]

open access: yesBiophysical Journal, 2010
The voltage-activated sodium channel Nav1.9 is preferentially expressed in DRG neurons where it is believed to play an important role in pain perception. However, progress in revealing the gating characteristics and pharmacological sensitivities of Nav1.9 has been slow because attempts to express this channel in a heterologous expression system have ...
Bosmans, Frank   +4 more
openaire   +1 more source

Association between Tetrodotoxin Resistant Channels and Lipid Rafts Regulates Sensory Neuron Excitability [PDF]

open access: yes, 2012
PubMed ID: 22870192This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Baker, MD, Okuse, K, Pristera, A
core   +6 more sources

Functional Properties and Toxin Pharmacology of a Dorsal Root Ganglion Sodium Channel Viewed through its Voltage Sensors [PDF]

open access: yes, 2013
The voltage-activated sodium (Nav) channel Nav1.9 is expressed in dorsal root ganglion (DRG) neurons where it is believed to play an important role in nociception.
Bean, Bruce Palmer   +4 more
core   +1 more source

Emergence of functional sensory subtypes as defined by transient receptor potential channel expression [PDF]

open access: yes, 2007
The existence of heterogeneous populations of dorsal root ganglion (DRG) neurons conveying different somatosensory information is the basis for the perception of touch, temperature, and pain. A differential expression of transient receptor potential (TRP)
AlQatari, M   +3 more
core   +1 more source

P2Y Receptors Sensitize Mouse and Human Colonic Nociceptors [PDF]

open access: yes, 2016
Activation of visceral nociceptors by inflammatory mediators contributes to visceral hypersensitivity and abdominal pain associated with many gastrointestinal disorders.
Baker, MD   +11 more
core   +1 more source

Suzetrigine, a Non-Opioid Small-Molecule Analgesic: Mechanism of Action, Clinical, and Translational Science. [PDF]

open access: yesClin Transl Sci
ABSTRACT The discovery and approval of Suzetrigine (VX‐548, Journavx) marks a significant breakthrough in pain management. It is the first non‐opioid analgesic approved since celecoxib in 1998. Suzetrigine selectively blocks voltage‐gated sodium channel Nav1.8 and acts exclusively on peripheral nociceptors without crossing the blood–brain barrier ...
Rajasingham R, Qi Y.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy